Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Molecular and Clinical Oncology
|
January 26, 2019
Inflammatory breast cancer in 210 patients: A retrospective study on epidemiological, anatomo-clinical features and therapeutic results
Maroua Manai, Pascal Finetti, Nesrine Mejri, et al.
Cancers
|
January 11, 2022
Single-Cells Isolation and Molecular Analysis: Focus on HER2-Low CTCs in Metastatic Breast Cancer
Paolo D'Amico, Carolina Reduzzi, Wenan Qiang, et al.
International Journal of Molecular Sciences
|
August 12, 2022
Dual Mechanism of Action of Curcumin in Experimental Models of Multiple Sclerosis
Ines ELBini-Dhouib, Maroua Manai, Nour-Elhouda Neili, et al.
Molecular Cancer Therapeutics
|
November 26, 2024
Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor-Positive Triple-Negative Breast Cancer by Inhibiting c-MYC-mediated Tumorigenesis
Xuemei Xie, Maroua Manai, Dileep R Rampa, et al.
Scientific Reports
|
November 20, 2024
Decoding the pathological and genomic profile of epithelial ovarian cancer
Rim Rejaibi, Arnaud Guille, Maroua Manai, et al.
International Journal of Molecular Sciences
|
January 4, 2018
Stromal Expression of MARCKS Protein in Ovarian Carcinomas Has Unfavorable Prognostic Value
Raoudha Doghri, Maroua Manai, Pascal Finetti, et al.
JCO Precision Oncology
|
July 12, 2023
Circulating Tumor DNA and Unique Actionable Genomic Alterations in the Longitudinal Monitoring of Metastatic Breast Cancer: A Case of <i>FGFR2-KIAA1598</i> Gene Fusion
Eleonora Nicolò, Laura Munoz-Arcos, Elena Vagia, et al.
Plos One
|
March 23, 2023
VISTA+/CD8+ status correlates with favorable prognosis in Epithelial ovarian cancer
Aida Jlassi, Maroua Manai, Maram Morjen, et al.
Oncotarget
|
December 24, 2016
MARCKS protein overexpression in inflammatory breast cancer
Maroua Manai, Jeanne Thomassin-Piana, Amor Gamoudi, et al.
Cancer Cell International
|
December 24, 2025
Quantitative HER2 profiling on circulating tumor cells using an EpCAM-independent platform in metastatic breast cancer
Nadia Bayou, Sarah Henretta, Laura Munoz-Arcos, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Molecular and Clinical Oncology
|
January 26, 2019
Inflammatory breast cancer in 210 patients: A retrospective study on epidemiological, anatomo-clinical features and therapeutic results
Maroua Manai, Pascal Finetti, Nesrine Mejri, et al.
Cancers
|
January 11, 2022
Single-Cells Isolation and Molecular Analysis: Focus on HER2-Low CTCs in Metastatic Breast Cancer
Paolo D'Amico, Carolina Reduzzi, Wenan Qiang, et al.
International Journal of Molecular Sciences
|
August 12, 2022
Dual Mechanism of Action of Curcumin in Experimental Models of Multiple Sclerosis
Ines ELBini-Dhouib, Maroua Manai, Nour-Elhouda Neili, et al.
Molecular Cancer Therapeutics
|
November 26, 2024
Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor-Positive Triple-Negative Breast Cancer by Inhibiting c-MYC-mediated Tumorigenesis
Xuemei Xie, Maroua Manai, Dileep R Rampa, et al.
Scientific Reports
|
November 20, 2024
Decoding the pathological and genomic profile of epithelial ovarian cancer
Rim Rejaibi, Arnaud Guille, Maroua Manai, et al.
International Journal of Molecular Sciences
|
January 4, 2018
Stromal Expression of MARCKS Protein in Ovarian Carcinomas Has Unfavorable Prognostic Value
Raoudha Doghri, Maroua Manai, Pascal Finetti, et al.
JCO Precision Oncology
|
July 12, 2023
Circulating Tumor DNA and Unique Actionable Genomic Alterations in the Longitudinal Monitoring of Metastatic Breast Cancer: A Case of <i>FGFR2-KIAA1598</i> Gene Fusion
Eleonora Nicolò, Laura Munoz-Arcos, Elena Vagia, et al.
Plos One
|
March 23, 2023
VISTA+/CD8+ status correlates with favorable prognosis in Epithelial ovarian cancer
Aida Jlassi, Maroua Manai, Maram Morjen, et al.
Oncotarget
|
December 24, 2016
MARCKS protein overexpression in inflammatory breast cancer
Maroua Manai, Jeanne Thomassin-Piana, Amor Gamoudi, et al.
Cancer Cell International
|
December 24, 2025
Quantitative HER2 profiling on circulating tumor cells using an EpCAM-independent platform in metastatic breast cancer
Nadia Bayou, Sarah Henretta, Laura Munoz-Arcos, et al.
Page
of 3